List of chemotherapeutic agents: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) |
Gerald Chi (talk | contribs) mNo edit summary |
||
(55 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Seealso|Chemotherapy regimens}} | {{Seealso|Chemotherapy regimens}} | ||
{{CMG}}; {{AE}} {{AV}}; {{Steven}} | {{CMG}}; {{AE}} {{AV}}; {{Steven}} | ||
Line 16: | Line 15: | ||
* [[Chlorambucil|Chlorambucil (Leukeran)]] | * [[Chlorambucil|Chlorambucil (Leukeran)]] | ||
* [[Cyclophosphamide|Cyclophosphamide (Cytoxan)]] | * [[Cyclophosphamide|Cyclophosphamide (Cytoxan)]] | ||
* [[Estramustine |Estramustine (Emcyt)]] | |||
* [[Ifosfamide|Ifosfamide (Iflex)]] | * [[Ifosfamide|Ifosfamide (Iflex)]] | ||
* [[Melphalan|Melphalan (Alkeran)]] | * [[Melphalan|Melphalan (Alkeran)]] | ||
Line 52: | Line 52: | ||
* [[Methotrexate|Methotrexate (Mexate, Folex)]] | * [[Methotrexate|Methotrexate (Mexate, Folex)]] | ||
* [[Pemetrexed|Pemetrexed (Alimta)]] | * [[Pemetrexed|Pemetrexed (Alimta)]] | ||
* [[Pralatrexate|Pralatrexate (Folotyn)]] | |||
====== Pyrimidine analogs ====== | ====== Pyrimidine analogs ====== | ||
Line 57: | Line 58: | ||
* [[Capecitabine|Capecitabine (Xeloda)]] | * [[Capecitabine|Capecitabine (Xeloda)]] | ||
* [[Cytarabine|Cytarabine (Cytosar)]] | * [[Cytarabine|Cytarabine (Cytosar)]] | ||
* [[Decitabine|Decitabine (Dacogen)]] | |||
* [[Floxuridine|Floxuridine (FUDR)]] | * [[Floxuridine|Floxuridine (FUDR)]] | ||
* [[Fluorouracil|Fluorouracil (Adrucil, Efudex)]] | * [[Fluorouracil|Fluorouracil (Adrucil, Efudex)]] | ||
* [[Gemcitabine|Gemcitabine (Gemzar)]] | * [[Gemcitabine|Gemcitabine (Gemzar)]] | ||
* [[Raltitrexed|Raltitrexed (Tomudex)]] | |||
====== Purine analogs ====== | ====== Purine analogs ====== | ||
Line 87: | Line 90: | ||
* [[Docetaxel|Docetaxel (Taxotere)]] | * [[Docetaxel|Docetaxel (Taxotere)]] | ||
* [[Paclitaxel|Paclitaxel (Taxol, Onxol)]] | * [[Paclitaxel|Paclitaxel (Taxol, Onxol)]] | ||
* [[Paclitaxel protein-bound|Paclitaxel protein-bound (Abraxane)]] | |||
====== Epipodophyllotoxins ====== | ====== Epipodophyllotoxins ====== | ||
Line 92: | Line 96: | ||
* [[Teniposide|Teniposide (Vumon)]] | * [[Teniposide|Teniposide (Vumon)]] | ||
====== Camptothecins | ====== Camptothecins ====== | ||
* [[Irinotecan|Irinotecan (Camptosar)]] | * [[Irinotecan|Irinotecan (Camptosar)]] | ||
* [[Topotecan|Topotecan (Hycamtin)]] | * [[Topotecan|Topotecan (Hycamtin)]] | ||
Line 99: | Line 103: | ||
* [[Bleomycin|Bleomycin (Blenoxane)]] | * [[Bleomycin|Bleomycin (Blenoxane)]] | ||
* [[Dactinomycin|Dactinomycin (Cosmegen)]] | * [[Dactinomycin|Dactinomycin (Cosmegen)]] | ||
* [[Daunorubicin|Daunorubicin (Daunoxome)]] | * [[Daunorubicin |Daunorubicin (Cerubidine)]] | ||
* [[Daunorubicin liposome|Daunorubicin liposome (Daunoxome)]] | |||
* [[Doxorubicin|Doxorubicin (Adriamycin, Rubex)]] | * [[Doxorubicin|Doxorubicin (Adriamycin, Rubex)]] | ||
* [[Epirubicin|Epirubicin (Ellence)]] | * [[Epirubicin|Epirubicin (Ellence)]] | ||
Line 105: | Line 110: | ||
* [[Mitomycin C|Mitomycin C (Mutamycin)]] | * [[Mitomycin C|Mitomycin C (Mutamycin)]] | ||
* [[Mitoxantrone|Mitoxantrone (Novantrone)]] | * [[Mitoxantrone|Mitoxantrone (Novantrone)]] | ||
* [[Pixantrone|Pixantrone (Pixuvri)]] | |||
* [[Plicamycin|Plicamycin (Mithracin)]] | |||
* [[Valrubicin|Valrubicin (Valstar)]] | * [[Valrubicin|Valrubicin (Valstar)]] | ||
Line 117: | Line 124: | ||
====== Adrenocortical suppressants ====== | ====== Adrenocortical suppressants ====== | ||
* [[Aminoglutethimide|Aminoglutethimide (Cytadren)]] | |||
* [[Mitotane|Mitotane (Lysodren)]] | * [[Mitotane|Mitotane (Lysodren)]] | ||
* [[Trilostane|Trilostane (Modrenal)]] | |||
====== | ====== Glucocorticoids ====== | ||
* [[Dexamethasone|Dexamethasone (Decadron)]] | |||
* [[Prednisone|Prednisone (Deltasone)]] | * [[Prednisone|Prednisone (Deltasone)]] | ||
====== Progestins ====== | ====== Progestins ====== | ||
* [[Medroxyprogesterone|Medroxyprogesterone (Provera)]] | * [[Medroxyprogesterone acetate|Medroxyprogesterone acetate (Provera)]] | ||
* [[Megestrol|Megestrol (Megace)]] | * [[Megestrol|Megestrol (Megace)]] | ||
====== Estrogens ====== | |||
* [[Esterified estrogens|Esterified estrogens (Menest)]] | |||
====== Anti-estrogens ====== | ====== Anti-estrogens ====== | ||
* [[Fulvestrant|Fulvestrant (Faslodex)]] | |||
* [[Raloxifene|Raloxifene (Evista)]] | |||
* [[Tamoxifen|Tamoxifen (Nolvadex)]] | * [[Tamoxifen|Tamoxifen (Nolvadex)]] | ||
* [[Toremifene|Toremifene (Fareston)]] | * [[Toremifene|Toremifene (Fareston)]] | ||
====== Aromatase inhibitors ====== | ====== Aromatase inhibitors ====== | ||
* [[Anastrozole|Anastrozole (Arimidex)]] | * [[Anastrozole|Anastrozole (Arimidex)]] | ||
* [[Exemestane|Exemestane (Aromasin)]] | * [[Exemestane|Exemestane (Aromasin)]] | ||
* [[Formestane|Formestane (Lentaron)]] | |||
* [[Letrozole|Letrozole (Femara)]] | * [[Letrozole|Letrozole (Femara)]] | ||
====== Androgens ====== | ====== Androgens ====== | ||
* [[Fluoxymesterone|Fluoxymesterone (Halotestin)]] | * [[Fluoxymesterone|Fluoxymesterone (Halotestin)]] | ||
* [[Testolactone|Testolactone (Teslac)]] | |||
====== Anti-androgens ====== | ====== Anti-androgens ====== | ||
Line 173: | Line 190: | ||
====== Anti-CD20 antibodies ====== | ====== Anti-CD20 antibodies ====== | ||
* [[Rituximab|Rituximab (Rituxan)]] | * [[Rituximab|Rituximab (Rituxan)]] | ||
* [[Ibritumomab|Ibritumomab (Zevalin)]] | * [[Ibritumomab tiuxetan|Ibritumomab tiuxetan (Zevalin))]] | ||
* [[Obinutuzumab|Obinutuzumab (Gazyva)]] | * [[Obinutuzumab|Obinutuzumab (Gazyva)]] | ||
* [[Ofatumumab|Ofatumumab (Arzerra)]] | * [[Ofatumumab|Ofatumumab (Arzerra)]] | ||
Line 200: | Line 217: | ||
====== Anti-HER2/neu (ErbB2) antibodies ====== | ====== Anti-HER2/neu (ErbB2) antibodies ====== | ||
* [[Ado-trastuzumab emtansine|Ado-trastuzumab (Kadcyla)]] | * [[Ado-trastuzumab emtansine|Ado-trastuzumab (Kadcyla)]] | ||
* [[Pertuzumab|Pertuzumab (Perjeta)]] | |||
* [[Trastuzumab|Trastuzumab (Herceptin)]] | * [[Trastuzumab|Trastuzumab (Herceptin)]] | ||
====== Anti-VEGF antibodies ====== | ====== Anti-VEGF antibodies ====== | ||
* [[Bevacizumab|Bevacizumab (Avastin)]] | * [[Bevacizumab|Bevacizumab (Avastin)]] | ||
* [[Ramucirumab|Ramucirumab (Cyramza)]] | |||
* [[ | |||
===== IL-6 inhibitors ===== | ===== IL-6 inhibitors ===== | ||
Line 214: | Line 229: | ||
===== Immunotherapy ===== | ===== Immunotherapy ===== | ||
* [[Aldesleukin|Aldesleukin (Proleukin)]] | |||
* [[Denileukin diftitox|Denileukin diftitox (Ontak)]] | |||
* [[Interferon alfa-2b|Interferon alfa-2b (Intron A)]] | * [[Interferon alfa-2b|Interferon alfa-2b (Intron A)]] | ||
* [[Peginterferon alfa-2a|Peginterferon alfa-2a (Pegasys)]] | |||
* [[Pegylated interferon alfa-2b|Peginterferon alfa-2b (Sylatron)]] | |||
---- | ---- | ||
Line 224: | Line 243: | ||
===== Granulocyte growth factors ===== | ===== Granulocyte growth factors ===== | ||
* [[Filgrastim|Filgrastim ( | * [[Filgrastim|Filgrastim (Neupogen)]] | ||
* [[Sargramostim|Sargramostin (Leukine)]] | * [[Pegfilgrastim|Pegfilgrastim (Neulasta)]] | ||
* [[Plerixafor|Plerixafor (Mozobil)]] | |||
* [[Sargramostim|Sargramostin (Leukine, Leukomax)]] | |||
* [[Tbo-filgrastim|Tbo-filgrastim (Granix)]] | * [[Tbo-filgrastim|Tbo-filgrastim (Granix)]] | ||
===== Megakaryocyte growth factors ===== | ===== Megakaryocyte growth factors ===== | ||
* [[Eltrombopag|Eltrombopag (Promacta)]] | * [[Eltrombopag|Eltrombopag (Promacta)]] | ||
* [[Oprelvekin|Oprelvekin (Neumega)]] | |||
---- | ---- | ||
Line 237: | Line 259: | ||
===== Chemotherapy protective agents ===== | ===== Chemotherapy protective agents ===== | ||
* [[Amifostine|Amifostine (Ethyol)]] | * [[Amifostine|Amifostine (Ethyol)]] | ||
* [[Cyanocobalamin|Cyanocobalamin]] | * [[Cyanocobalamin|Cyanocobalamin (Cobal)]] | ||
* [[Dexrazoxane|Dexrazoxane (Zinecard)]] | * [[Dexrazoxane|Dexrazoxane (Zinecard)]] | ||
* [[Folinic acid|Folinic acid (Leucovorin)]] | * [[Folinic acid|Folinic acid (Leucovorin Calcium)]] | ||
* [[Glucarpidase|Glucarpidase (Voraxaze)]] | * [[Glucarpidase|Glucarpidase (Voraxaze)]] | ||
* [[Levoleucovorin|Levoleucovorin (Fusilev)]] | * [[Levoleucovorin|Levoleucovorin (Fusilev)]] | ||
* [[Mesna|Mesna (Mesnex)]] | * [[Mesna|Mesna (Mesnex)]] | ||
* [[Rasburicase|Rasburicase (Elitek)]] | |||
===== Antiemetic agents ===== | ===== Antiemetic agents ===== | ||
Line 249: | Line 272: | ||
===== RANK ligand inhibitors ===== | ===== RANK ligand inhibitors ===== | ||
* [[Denosumab|Denosumab (Xgeva)]] | * [[Denosumab|Denosumab (Xgeva)]] | ||
===== Calcium regulators ===== | |||
* [[Gallium nitrate|Gallium nitrate (Ganite)]] | |||
* [[Pamidronate|Pamidronate (Aredia)]] | |||
* [[Zoledronic Acid|Zoledronic Acid (Zometa)]] | |||
---- | ---- | ||
Line 259: | Line 287: | ||
* [[Eribulin|Eribulin (Halaven)]] | * [[Eribulin|Eribulin (Halaven)]] | ||
* [[Ixabepilone|Ixabepilone (Ixempra)]] | * [[Ixabepilone|Ixabepilone (Ixempra)]] | ||
===== HDAC inhibitors ===== | ===== HDAC inhibitors ===== | ||
Line 274: | Line 299: | ||
* [[Lenalidomide|Lenalidomide (Revlimid)]] | * [[Lenalidomide|Lenalidomide (Revlimid)]] | ||
* [[Pomalidomide|Pomalidomide (Pomalyst)]] | * [[Pomalidomide|Pomalidomide (Pomalyst)]] | ||
* [[Sipuleucel-T|Sipuleucel-T (Provenge)]] | |||
* [[Thalidomide|Thalidomide (Thalomid)]] | |||
===== Kinase inhibitors ===== | ===== Kinase inhibitors ===== | ||
Line 282: | Line 309: | ||
* [[Ceritinib|Ceritinib (Zykadia)]] | * [[Ceritinib|Ceritinib (Zykadia)]] | ||
* [[Crizotinib|Crizotinib (Xalkori)]] | * [[Crizotinib|Crizotinib (Xalkori)]] | ||
* [[Dabrafenib|Dabrafenib (Tafinlar)]] | |||
* [[Dasatinib|Dasatinib (Sprycel)]] | * [[Dasatinib|Dasatinib (Sprycel)]] | ||
* [[Erlotinib|Erlotinib (Tarceva)]] | * [[Erlotinib|Erlotinib (Tarceva)]] | ||
* [[Everolimus|Everolimus (Afinitor)]] | |||
* [[Gefitinib|Gefitinib (Iressa)]] | * [[Gefitinib|Gefitinib (Iressa)]] | ||
* [[Ibrutinib|Ibrutinib (Imbruvica)]] | * [[Ibrutinib|Ibrutinib (Imbruvica)]] | ||
* [[Idelalisib|Idelalisib (Zydelig)]] | * [[Idelalisib|Idelalisib (Zydelig)]] | ||
* [[Imatinib|Imatinib (Gleevec)]] | |||
* [[Lapatinib|Lapatinib (Tykerb)]] | * [[Lapatinib|Lapatinib (Tykerb)]] | ||
* [[Lenvatinib|Lenvatinib (Lenvima)]] | |||
* [[Nilotinib|Nilotinib (Tasigna)]] | * [[Nilotinib|Nilotinib (Tasigna)]] | ||
* [[Palbociclib|Palbociclib (Ibrance)]] | * [[Palbociclib|Palbociclib (Ibrance)]] | ||
* [[Regorafenib|Regorafenib (Stivarga)]] | |||
* [[Ruxolitinib|Ruxolitinib (Jakafi)]] | |||
* [[Sorafenib|Sorafenib (Nexavar)]] | * [[Sorafenib|Sorafenib (Nexavar)]] | ||
* [[Sunitinib|Sunitinib (Sutent)]] | * [[Sunitinib|Sunitinib (Sutent)]] | ||
* [[Temsirolimus|Temsirolimus (Torisel)]] | |||
* [[Trametinib|Trametinib (Mekinist)]] | * [[Trametinib|Trametinib (Mekinist)]] | ||
* [[Vandetanib|Vandetanib (Caprelsa)]] | * [[Vandetanib|Vandetanib (Caprelsa)]] | ||
* [[Vemurafenib|Vemurafenib (Zelboraf)]] | * [[Vemurafenib|Vemurafenib (Zelboraf)]] | ||
* [[Ziv-aflibercept|Ziv-aflibercept (Zaltrap)]] | * [[Ziv-aflibercept|Ziv-aflibercept (Zaltrap)]] | ||
===== Photosensitizing agents ===== | ===== Photosensitizing agents ===== | ||
* [[Aminolevulinic acid |Aminolevulinic acid (Levulan)]] | * [[Aminolevulinic acid |Aminolevulinic acid (Levulan)]] | ||
* [[Porfimer|Porfimer (Photofrin)]] | |||
===== Proteasome inhibitors ===== | ===== Proteasome inhibitors ===== | ||
Line 314: | Line 345: | ||
* [[Octreotide|Octreotide (Octreotide)]] | * [[Octreotide|Octreotide (Octreotide)]] | ||
===== | ===== Differentiating agents ===== | ||
* [[Arsenic trioxide|Arsenic trioxide (Trisenox)]] | |||
* [[Bexarotene|Bexarotene (Targretin)]] | * [[Bexarotene|Bexarotene (Targretin)]] | ||
* [[Tretinoin|Tretinoin (Vesanoid)]] | * [[Tretinoin|Tretinoin (Vesanoid)]] | ||
===== | ===== Orphan drugs ===== | ||
* [[ | * [[Olaparib|Olaparib (Lynparza)]] | ||
* [[Omacetaxine|Omacetaxine (Synribo)]] | |||
* [[Ranpirnase|Ranpirnase (Onconase)]] | |||
* [[Trabectedin|Trabectedin (Yondelis)]] | |||
== Chemotherapeutic Agents in Alphabetical Order == | == Chemotherapeutic Agents in Alphabetical Order == | ||
{{Columns-list| | {{Columns-list|3| | ||
* [[Abarelix|Abarelix (Plenaxis)]] | * [[Abarelix|Abarelix (Plenaxis)]] | ||
* [[Abiraterone|Abiraterone acetate (Zytiga)]] | * [[Abiraterone|Abiraterone acetate (Zytiga)]] | ||
Line 505: | Line 540: | ||
* [[Trastuzumab|Trastuzumab (Herceptin)]] | * [[Trastuzumab|Trastuzumab (Herceptin)]] | ||
* [[Tretinoin|Tretinoin (Vesanoid)]] | * [[Tretinoin|Tretinoin (Vesanoid)]] | ||
* [[Trilostane|Trilostane ( | * [[Trilostane|Trilostane (Modrenal)]] | ||
* [[Triptorelin pamoate|Triptorelin pamoate (Trelstar)]] | * [[Triptorelin pamoate|Triptorelin pamoate (Trelstar)]] | ||
* [[Valrubicin|Valrubicin (Valstar)]] | * [[Valrubicin|Valrubicin (Valstar)]] |
Latest revision as of 04:08, 22 March 2015
Template:Seealso Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]; Steven Bellm, M.D. [3]
Overview
This is a list of chemotherapeutic agents that are known to be of use in chemotherapy for cancer. A full alphabetical listing is included after the categorical listing.
The agents in this list are often combined into chemotherapy regimens for polychemotherapy (combination chemotherapy).
Chemotherapeutic Agents by Category
Alkylating agents
Nitrogen mustards
- Chlorambucil (Leukeran)
- Cyclophosphamide (Cytoxan)
- Estramustine (Emcyt)
- Ifosfamide (Iflex)
- Melphalan (Alkeran)
- Mechlorethamine (Mustargen)
Ethylenimines
Methylhydrazines
Alkylsulfonates
Nitrosoureas
Triazenes
Platinum coordination complexes
Antimetabolites
Folic acid analogs
Pyrimidine analogs
- Azacytidine (Vidaza)
- Capecitabine (Xeloda)
- Cytarabine (Cytosar)
- Decitabine (Dacogen)
- Floxuridine (FUDR)
- Fluorouracil (Adrucil, Efudex)
- Gemcitabine (Gemzar)
- Raltitrexed (Tomudex)
Purine analogs
- Cladribine (Leustatin)
- Clofarabine (Clolar)
- Fludarabine (Fludara)
- Mercaptopurine (Purinethol)
- Nelarabine (Arranon)
- Pentostatin (Nipent)
- Thioguanine (Tabloid)
Ribonucleotide reductase inhibitors
Natural products
Vinca alkaloids
- Vinblastine (Velban, Velsar)
- Vincristine (Oncovin, Vincasar)
- Vincristine liposome (Marqibo)
- Vinflunine (Javlor)
- Vinorelbine (Navelbine)
Taxanes
Epipodophyllotoxins
Camptothecins
Antineoplastic antibiotics
- Bleomycin (Blenoxane)
- Dactinomycin (Cosmegen)
- Daunorubicin (Cerubidine)
- Daunorubicin liposome (Daunoxome)
- Doxorubicin (Adriamycin, Rubex)
- Epirubicin (Ellence)
- Idarubicin (Idamycin)
- Mitomycin C (Mutamycin)
- Mitoxantrone (Novantrone)
- Pixantrone (Pixuvri)
- Plicamycin (Mithracin)
- Valrubicin (Valstar)
Antineoplastic enzymes
Hormones and Antagonists
Adrenocortical suppressants
Glucocorticoids
Progestins
Estrogens
Anti-estrogens
Aromatase inhibitors
Androgens
Anti-androgens
- Abarelix (Plenaxis)
- Abiraterone (Zytiga)
- Bicalutamide (Casodex)
- Enzalutamide (Xtandi)
- Flutamide (Eulexin)
- Nilutamide (Nilandron)
LHRH agonists
GnRH agonists
GnRH antagonists
Biologics
Monoclonal antibodies
Anti-CD3 antibodies
Anti-CD3 & anti-CD19 antibodies
Anti-CD20 antibodies
- Rituximab (Rituxan)
- Ibritumomab tiuxetan (Zevalin))
- Obinutuzumab (Gazyva)
- Ofatumumab (Arzerra)
- Tositumomab (Bexxar)
Anti-CD30 antibodies
Anti-CD33 antibodies
Anti-CD52 antibodies
Anti-CTLA–4 antibodies
Anti-EGFR (ErbB1) antibodies
Anti-PD–1 antibodies
Anti-HER2/neu (ErbB2) antibodies
Anti-VEGF antibodies
IL-6 inhibitors
Immunotherapy
- Aldesleukin (Proleukin)
- Denileukin diftitox (Ontak)
- Interferon alfa-2b (Intron A)
- Peginterferon alfa-2a (Pegasys)
- Peginterferon alfa-2b (Sylatron)
Hematopoietic Growth Factors
Erythrocyte growth factors
Granulocyte growth factors
- Filgrastim (Neupogen)
- Pegfilgrastim (Neulasta)
- Plerixafor (Mozobil)
- Sargramostin (Leukine, Leukomax)
- Tbo-filgrastim (Granix)
Megakaryocyte growth factors
Supportive Medications
Chemotherapy protective agents
- Amifostine (Ethyol)
- Cyanocobalamin (Cobal)
- Dexrazoxane (Zinecard)
- Folinic acid (Leucovorin Calcium)
- Glucarpidase (Voraxaze)
- Levoleucovorin (Fusilev)
- Mesna (Mesnex)
- Rasburicase (Elitek)
Antiemetic agents
RANK ligand inhibitors
Calcium regulators
Miscellaneous
Mitotic inhibitors
HDAC inhibitors
Hedgehog pathway inhibitors
Immunomodulatory drugs (IMiDs)
Kinase inhibitors
- Afatinib (Gliotrif)
- Axitinib (Inlyta)
- Bosutinib (Bosulif)
- Cabozantinib (Cometriq)
- Ceritinib (Zykadia)
- Crizotinib (Xalkori)
- Dabrafenib (Tafinlar)
- Dasatinib (Sprycel)
- Erlotinib (Tarceva)
- Everolimus (Afinitor)
- Gefitinib (Iressa)
- Ibrutinib (Imbruvica)
- Idelalisib (Zydelig)
- Imatinib (Gleevec)
- Lapatinib (Tykerb)
- Lenvatinib (Lenvima)
- Nilotinib (Tasigna)
- Palbociclib (Ibrance)
- Regorafenib (Stivarga)
- Ruxolitinib (Jakafi)
- Sorafenib (Nexavar)
- Sunitinib (Sutent)
- Temsirolimus (Torisel)
- Trametinib (Mekinist)
- Vandetanib (Caprelsa)
- Vemurafenib (Zelboraf)
- Ziv-aflibercept (Zaltrap)
Photosensitizing agents
Proteasome inhibitors
Radioactive agents
Somatostatin analogs
Differentiating agents
Orphan drugs
Chemotherapeutic Agents in Alphabetical Order
The unnamed parameter 2= is no longer supported. Please see the documentation for {{columns-list}}.
3